150 related articles for article (PubMed ID: 36660048)
1. Antibiotic prophylaxis and its effect on postprocedural adverse events in endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis.
Gustafsson A; Enochsson L; Tingstedt B; Olsson G
JGH Open; 2023 Jan; 7(1):24-29. PubMed ID: 36660048
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic prophylaxis and post-procedure infectious complications in endoscopic retrograde cholangiopancreatography with peroral cholangioscopy.
Gustafsson A; Enochsson L; Tingstedt B; Olsson G
Endosc Int Open; 2023 Dec; 11(12):E1177-E1183. PubMed ID: 38094034
[No Abstract] [Full Text] [Related]
3. Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography.
von Seth E; Arnelo U; Enochsson L; Bergquist A
Liver Int; 2015 Jan; 35(1):254-62. PubMed ID: 25041074
[TBL] [Abstract][Full Text] [Related]
4. The role of antibiotic prophylaxis in routine endoscopic retrograde cholangiopancreatography investigations as assessed prospectively in a nationwide study cohort.
Olsson G; Arnelo U; Lundell L; Persson G; Törnqvist B; Enochsson L
Scand J Gastroenterol; 2015 Jul; 50(7):924-31. PubMed ID: 25769041
[TBL] [Abstract][Full Text] [Related]
5. ERCP-related adverse events in patients with primary sclerosing cholangitis.
Navaneethan U; Jegadeesan R; Nayak S; Lourdusamy V; Sanaka MR; Vargo JJ; Parsi MA
Gastrointest Endosc; 2015 Feb; 81(2):410-9. PubMed ID: 25085336
[TBL] [Abstract][Full Text] [Related]
6. ERCP-Related Adverse Events in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.
Natt N; Michael F; Michael H; Dubois S; Al Mazrou'i A
Can J Gastroenterol Hepatol; 2022; 2022():2372257. PubMed ID: 35910039
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic prophylaxis in ERCP with failed cannulation.
Olsson G; Enochsson L; Swahn F; Andersson B
Scand J Gastroenterol; 2021 Mar; 56(3):336-341. PubMed ID: 33399493
[TBL] [Abstract][Full Text] [Related]
8. Is It Safe to Perform Endoscopic Retrograde Cholangiopancreatography in Decompensated Cirrhosis?
Jagtap N; Nabi Z; Tandan M; Ramchandani M; Sharma M; Lakhtakia S; Rao PN; Gupta R; Kalapala R; Basha J; Darishetty S; Rao GV; Reddy DN
J Clin Exp Hepatol; 2019; 9(5):554-560. PubMed ID: 31695244
[TBL] [Abstract][Full Text] [Related]
9. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis.
Bangarulingam SY; Gossard AA; Petersen BT; Ott BJ; Lindor KD
Am J Gastroenterol; 2009 Apr; 104(4):855-60. PubMed ID: 19259076
[TBL] [Abstract][Full Text] [Related]
10. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography.
Enns R; Eloubeidi MA; Mergener K; Jowell PS; Branch MS; Baillie J
Can J Gastroenterol; 2003 Apr; 17(4):243-8. PubMed ID: 12704468
[TBL] [Abstract][Full Text] [Related]
11. Comorbidities, sphincterotomy, and balloon dilation predict post-ERCP adverse events in PSC patients: operator experience is protective.
Alkhatib AA; Hilden K; Adler DG
Dig Dis Sci; 2011 Dec; 56(12):3685-8. PubMed ID: 21789539
[TBL] [Abstract][Full Text] [Related]
12. Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis.
Rupp C; Hippchen T; Bruckner T; Klöters-Plachky P; Schaible A; Koschny R; Stiehl A; Gotthardt DN; Sauer P
Gut; 2019 Dec; 68(12):2170-2178. PubMed ID: 30910856
[TBL] [Abstract][Full Text] [Related]
13. Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group.
van den Hazel SJ; Wolfhagen EH; van Buuren HR; van de Meeberg PC; Van Leeuwen DJ
Endoscopy; 2000 Oct; 32(10):779-82. PubMed ID: 11068837
[TBL] [Abstract][Full Text] [Related]
14. Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography.
Koskensalo V; Tenca A; Udd M; Lindström O; Rainio M; Jokelainen K; Kylänpää L; Färkkilä M
United European Gastroenterol J; 2020 May; 8(4):462-471. PubMed ID: 32213036
[TBL] [Abstract][Full Text] [Related]
15. Inversed relationship between completeness of follow-up and coverage of postoperative complications in gallstone surgery and ERCP: a potential source of bias in patient registers.
Enochsson L; Blohm M; Sandblom G; Jonas E; Hallerbäck B; Lundell L; Österberg J
BMJ Open; 2018 Jan; 8(1):e019551. PubMed ID: 29362270
[TBL] [Abstract][Full Text] [Related]
16. Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis.
Waldthaler A; Schramm C; Bergquist A
Eur J Med Genet; 2021 Jun; 64(6):104231. PubMed ID: 33905896
[TBL] [Abstract][Full Text] [Related]
17. New approach to decrease post-ERCP adverse events in patients with primary sclerosing cholangitis.
Navaneethan U; Lourdusamy D; Gutierrez NG; Zhu X; Vargo JJ; Parsi MA
Endosc Int Open; 2017 Aug; 5(8):E710-E717. PubMed ID: 28791317
[TBL] [Abstract][Full Text] [Related]
18. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial.
van den Hazel SJ; Speelman P; Dankert J; Huibregtse K; Tytgat GN; van Leeuwen DJ
Ann Intern Med; 1996 Sep; 125(6):442-7. PubMed ID: 8779455
[TBL] [Abstract][Full Text] [Related]
19. ERCP-guided cholangioscopy using a single-use system: nationwide register-based study of its use in clinical practice.
Lübbe J; Arnelo U; Lundell L; Swahn F; Törnqvist B; Jonas E; Löhr JM; Enochsson L
Endoscopy; 2015 Sep; 47(9):802-7. PubMed ID: 25910063
[TBL] [Abstract][Full Text] [Related]
20. Older age, longer procedures and tandem endoscopic-ultrasound as risk factors for post-endoscopic retrograde cholangiopancreatography bacteremia.
Deutsch L; Matalon S; Phillips A; Leshno M; Shibolet O; Santo E
World J Gastroenterol; 2020 Nov; 26(41):6402-6413. PubMed ID: 33244201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
